Improved Automatic Morphology-Based Classification of Parkinson’s Disease and Progressive Supranuclear Palsy
- 97 Downloads
The overlapping symptoms of Parkinson’s disease (PD) and progressive supranuclear palsy—Richardson’s syndrome (PSP-RS) often make a correct clinical diagnosis difficult. The volume of subcortical brain structures derived from high-resolution T1-weighted magnetic resonance imaging (MRI) datasets is frequently used for individual level classification of PD and PSP-RS patients. The aim of this study was to evaluate the benefit of including additional morphological features beyond the simple regional volume, as well as clinical features, and morphological features of cortical structures for an automatic classification of PD and PSP-RS patients.
Material and Methods
A total of 98 high-resolution T1-weighted MRI datasets from 76 PD patients, and 22 PSP-RS patients were available for this study. Using an atlas-based approach, the volume, surface area, and surface-area-to-volume ratio (SA:V) of 21 subcortical and 48 cortical brain regions were calculated and used as features for a support vector machine classification after application of a RELIEF feature selection method.
The comparison of the classification results suggests that including all three morphological parameters (volume, surface area and SA:V) can considerably improve classification accuracy compared to using volume or surface area alone. Likewise, including clinical patient features in addition to morphological parameters also considerably increases the classification accuracy. In contrast to this, integrating morphological features of other cortical structures did not lead to improved classification accuracy. Using this optimal set-up, an accuracy of 98% was achieved with only one falsely classified PD and one falsely classified PSP-RS patient.
The results of this study suggest that clinical features as well as more advanced morphological features should be used for future computer-aided diagnosis systems to differentiate PD and PSP-RS patients based on morphological parameters.
KeywordsMagnetic resonance imaging T1 image sequences Computer-assisted image Analysis Parkinson’s disease Progressive supranuclear palsy
This work was supported by Parkinson Alberta.
Conflict of interest
A.S. Talai, Z. Ismail, J. Sedlacik, K. Boelmans and N.D. Forkert declare that they have no competing interests.
- 2.Olanow CW, Hauser RA, Jankovic J, Langston W, Lang A, Poewe W, Tolosa E, Stocchi F, Melamed E, Eyal E, Rascol O. A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson’s disease (the ADAGIO study): rationale, design, and baseline characteristics. Mov Disord. 2008;23:2194–201.CrossRefPubMedCentralGoogle Scholar
- 3.Pellicano C, Assogna F, Cellupica N, Piras F, Pierantozzi M, Stefani A, Cerroni R, Mercuri B, Caltagirone C, Pontieri FE, Spalletta G. Neuropsychiatric and cognitive profile of early Richardson’s syndrome, progressive supranuclear Palsy-parkinsonism and Parkinson’s disease. Parkinsonism Relat Disord. 2017;45:50–6.CrossRefPubMedCentralGoogle Scholar
- 5.Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology. 1996;47:1–9.CrossRefGoogle Scholar
- 8.Marx S, Respondek G, Stamelou M, Dowiasch S, Stoll J, Bremmer F, Oertel WH, Höglinger GU, Einhäuser W. Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson’s disease. Front Behav Neurosci. 2012;6:1–11.Google Scholar
- 11.Eckert T, Sailer M, Kaufmann J, Schrader C, Peschel T, Bodammer N, Heinze HJ, Schoenfeld MA. Differentiation of idiopathic Parkinson’s disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. Neuroimage. 2004;21:229–35.CrossRefPubMedCentralGoogle Scholar
- 14.Quattrone A, Nicoletti G, Messina D, Fera F, Condino F, Pugliese P, Lanza P, Barone P, Morgante L, Zappia M, Aguglia U, Gallo O. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology. 2008;246:214–21.CrossRefPubMedCentralGoogle Scholar
- 16.Focke NK, Helms G, Scheewe S, Pantel PM, Bachmann CG, Dechent P, Ebentheuer J, Mohr A, Paulus W, Trenkwalder C. Individual voxel-based subtype prediction can differentiate progressive supranuclear palsy from idiopathic Parkinson syndrome and healthy controls. Hum Brain Mapp. 2011;32:1905–15.CrossRefPubMedCentralGoogle Scholar
- 20.Sarica A, Critelli C, Guzzi PH, Cerasa A, Quattrone A, Cannataro M. Application of different classification techniques on brain morphological data. Comput Med Syst (CBMS), 2013 IEEE 26th Int Symp on IEEE. 2013. pp. 425–8.Google Scholar
- 22.Sakurai K, Tokumaru AM, Shimoji K, Murayama S, Kanemaru K, Morimoto S, Aiba I, Nakagawa M, Ozawa Y, Shimohira M, Matsukawa N, Hashizume Y, Shibamoto Y. Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy. Neuroradiology. 2017;59:431–43.CrossRefPubMedCentralGoogle Scholar
- 25.Gerrits NJ, van Loenhoud AC, van den Berg SF, Berendse HW, Foncke EM, Klein M, Stoffers D, van der Werf YD, van den Heuvel OA. Cortical thickness, surface area and subcortical volume differentially contribute to cognitive heterogeneity in Parkinson’s disease. PLoS ONE. 2016;11:1–14.CrossRefGoogle Scholar
- 27.Worker A, Blain C, Jarosz J, Chaudhuri KR, Barker GJ, Williams SC, Brown R, Leigh PN, Simmons A. Cortical thickness, surface area and volume measures in Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy. PLoS ONE. 2014;9:1–15.Google Scholar
- 30.Long D, Wang J, Xuan M, Gu Q, Xu X, Kong D, Zhang M. Automatic classification of early Parkinson’s disease with multi-modal MR imaging. PLoS ONE. 2012;7:1–9.Google Scholar
- 31.Péran P, Cherubini A, Assogna F, Piras F, Quattrocchi C, Peppe A, Celsis P, Rascol O, Démonet JF, Stefani A, Pierantozzi M, Pontieri FE, Caltagirone C, Spalletta G, Sabatini U. Magnetic resonance imaging markers of Parkinson’s disease nigrostriatal signature. Brain. 2010;133:3423–33.CrossRefGoogle Scholar
- 32.Morisi R, Cha M, Arafa M, Zagrouba E. Binary and multi-class parkinsonian disorders classification using support vector machines. In: Lecture notes in computer science. 2015. pp. 379–86.Google Scholar
- 38.Mazziotta J, Toga A, Evans A, Fox P, Lancaster J, Zilles K, Woods R, Paus T, Simpson G, Pike B, Holmes C, Collins L, Thompson P, MacDonald D, Iacoboni M, Schormann T, Amunts K, Palomero-Gallagher N, Geyer S, Parsons L, Narr K, Kabani N, Le Goualher G, Boomsma D, Cannon T, Kawashima R, Mazoyer B. A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos Trans R Soc Lond, B, Biol Sci. 2001;356:1293–322.CrossRefPubMedCentralGoogle Scholar
- 45.Salvatore C, Cerasa A, Castiglioni I, Gallivanone F, Augimeri A, Lopez M, Arabia G, Morelli M, Gilardi MC, Quattrone A. Machine learning on brain MRI data for differential diagnosis of Parkinson’s disease and progressive supranuclear palsy. J Neurosci Methods. 2014;222:230–7.CrossRefPubMedCentralGoogle Scholar